Moffitt Cancer Center
Moffitt Cancer Center Purpose Built to Beat Cancer, 30 - Spanish Subtitles
0:31
Moffitt Cancer Center
Moffitt Day 2025
1:30
Moffitt Cancer Center
Moffitt Gastrointestinal Cancer, 30 - Spanish Subtitles
0:31
Moffitt Cancer Center
Moffitt Cancer Center: Above The Rest 15, Spanish Subtitles
0:16
Moffitt Cancer Center
2025 Moffitt Day at the Capitol - Cure on Wheels Cyclists Arrival
7:08
Moffitt Cancer Center
Why I Became a Registered Dietitian | Celebrating RDN Day at Moffitt
0:33
Moffitt Cancer Center
Moffitt Cancer Center: Above The Rest, 60 Spanish Subtitles
1:01
Moffitt Cancer Center
Moffitt Cancer Center: Above The Rest, 30 Spanish Subtitles
0:31
Moffitt Cancer Center
Moffitt Cancer Center: Above The Rest, 15 ( ALT ) Spanish Subtitles
0:16
Moffitt Cancer Center
Dr. Brian Czerniecki on Tampa Bay's Morning Blend
4:17
Moffitt Cancer Center
Moffitt Cancer Center: Purpose Built to Beat Cancer 60
1:01
Moffitt Cancer Center
Moffitt Cancer Center: Purpose Built to Beat Cancer 30
0:31
Moffitt Cancer Center
Dr. Sarah Hoffe on Suncoast View
5:01
Moffitt Cancer Center
Dr. Adam Luchey on Tampa Bay's Morning Blend
4:13
Moffitt Cancer Center
The Impact of Clinical Social Workers | National Social Work Month
0:26
Moffitt Cancer Center
The Cancer Cookbook: Baked Apple Yogurt Parfait
2:14
Moffitt Cancer Center
Finding Your Way Around Moffitt McKinley Hospital.
6:43
Moffitt Cancer Center
Moffitt Cancer Center at Southshore: Top Cancer Care in Florida Near South Hillsborough
1:01
Moffitt Cancer Center
What is Occupational Therapy? - Moffitt Cancer Center
2:11
Moffitt Cancer Center
Improving Urinary Urgency, Frequency and Urge Incontinence - Moffitt Cancer Center
9:20
Moffitt Cancer Center
Palliative Care vs Hospice: Debunking Myths About End of Life Care
0:30
Moffitt Cancer Center
Dr. Timothy Kubal on Suncoast View
5:39
Moffitt Cancer Center
Moffitt Cancer Center Above The Rest
0:31
Moffitt Cancer Center
Alexander Anderson, PhD on Integrated Mathematical Oncology Team is Advancing Evolutionary Therapy
1:09
Moffitt Cancer Center
Suehelay Acevedo Acevedo, PhD Presents on Advancing #LungCancer Research With 3D Ex-Vivo Models
1:00
Moffitt Cancer Center
Kaitlyn Miranda Investigates How Pramlintide Targets ΔNp63 in Squamous Cancers
3:08
Moffitt Cancer Center
A. Sanem Yilmaz Presents How Myeloid Cells Shape the Tumor Microenvironment
1:49
Moffitt Cancer Center
Elsa Flores, PhD Highlights Moffitt’s Division of Basic Science
0:17
Moffitt Cancer Center
Karen Lu, MD Highlights the Power of a Multidisciplinary Approach to Drive Innovation in Cancer Care
1:12
Moffitt Cancer Center
Chandler Gatenbee, PhD Presents His Research on CAR T Cell Therapy for Large B Cell Lymphoma (LBCL)
2:14
Moffitt Cancer Center
Dennis Discher, PhD from UPenn Explores the Power of Engineering Anti-Tumor Macrophages
0:38
Moffitt Cancer Center
Cancer Engineering Summit 2025 - Engineering Cancer’s End™
0:49
Moffitt Cancer Center
Have You Scheduled Your Cancer Screening Yet?
0:09
Moffitt Cancer Center
Alex Dojcinovski: Bringing Hope to Patients
14:31
Moffitt Cancer Center
2025 Magnolia Ball Benefitting Moffitt Cancer Center
1:09
Moffitt Cancer Center
2025 Cancer Engineering Summit - Moffitt Cancer Center
0:49
Moffitt Cancer Center
Dr. Vania Phuoc on Suncoast View
4:13
Moffitt Cancer Center
Welcome to Tandem 2025 - Moffitt Cancer Center
1:03
Moffitt Cancer Center
Moffitt Pet Therapy Dog's Big Game Pick
0:18
Moffitt Cancer Center
2025 Magnolia Ball Patient Testimonial: Bob Snedeker
3:37
Moffitt Cancer Center
Cristina Naso - Conectados por Tu Salud
36:11
Moffitt Cancer Center
The Cancer Cookbook: Garlic Greens and Mushrooms
2:03
Moffitt Cancer Center
Blood Donations Benefits: 10 Reasons Why to Donate Blood
0:08
Moffitt Cancer Center
An Insider's Look: Innovations in Malignant Hematology Research
1:05:11
Moffitt Cancer Center
Honoring the Legacy of MLK
0:13
Moffitt Cancer Center
The Cancer Cookbook: Salmon Fillet with Yogurt Avocado Sauce
2:39
Moffitt Cancer Center
SouthShore Grand Opening - Moffitt Cancer Center
1:01
Moffitt Cancer Center
Grand Opening of Moffitt Cancer Center SouthShore
20:51
Moffitt Cancer Center
Randy Isaacson: Leukemia Was Only 162 Days of Our Amazing Life
12:26
Moffitt Cancer Center
Thoracic Cancer Treatment with Dr. Sam Freyaldenhoven
4:17
Moffitt Cancer Center
First Day of Winter: Elf on the Shelf Brings Snowball Fun to Moffitt
0:12
Moffitt Cancer Center
Gifts of Gratitude 2024 - Moffitt Cancer Center
2:03
Moffitt Cancer Center
Moffitt Cancer Center Treats First Synovial Sarcoma Patient with FDA Approved Cell Therapy
2:39
Moffitt Cancer Center
Dr. Matt Schabath - Bringing your whole self
35:31
Moffitt Cancer Center
LIVE: The 2024 ReMissions Holiday Sing-Along from Moffitt Cancer Center
32:47
Moffitt Cancer Center
Tips for Coping with Cancer During the Holidays
0:22
Moffitt Cancer Center
ASH 2024: Ziad Abuhelwa, MD Discusses Outcomes in MDS Patients Comparing IDH1-MT vs. Wild-Type
2:39
Moffitt Cancer Center
ASH 2024: Praneeth Reddy Sudalagunta, PhD on Bridging MM Therapy Effects with Idecabtagene-Vicleucel
1:22
Moffitt Cancer Center
ASH 2024: Abida Babu on Fludarabine-Melphalan vs. Fludarabine-Busulfan in AML Transplant Outcomes
2:45
Moffitt Cancer Center
ASH 2024: Wael Gamal, PhD on PI3K Inhibition to Enhance CAR T-Cell Therapy in CLL
2:00
Moffitt Cancer Center
ASH 2024: Bijal Shah, MD on Healthcare Costs and Resource Use in Managing CRS/ICANS with ObeCART
2:42
Moffitt Cancer Center
ASH 2024: David Sallman, MD on MRD Evaluation via NGS with CPX-351 in Acute Myeloid Leukemia
2:38
Moffitt Cancer Center
ASH 2024: Jeremy DiGennaro, DO on Pacritinib, Momelotinib Use and Outcomes in Myelofibrosis
4:34
Moffitt Cancer Center
ASH 2024: Nelli Bejanyan, MD on Donor Gamma Delta T-Cell Therapy to Prevent AML Relapse
2:59
Moffitt Cancer Center
ASH 2024: Ziad Abuhelwa, MD on Patterns & Outcomes in Myeloma After Anti-BCMA CAR T Therapy
3:01
Moffitt Cancer Center
ASH 2024: Faustine Ong, MD Discusses Disparities in AML Survival in the Targeted Therapy Era
4:29
Moffitt Cancer Center
ASH 2024: Ciara Freeman, MD on New CAR T Therapy with High Success & Manageable Side Effects
1:49
Moffitt Cancer Center
ASH 2024: Hammad Tashkandi, MD on TP53-Mutated MDS Subgrouping & Prognostic Insights from WHO & ICC
4:14
Moffitt Cancer Center
ASH 2024: Lauren Peres, PhD Highlights Racial & Ethnic Outcomes in Multiple Myeloma CAR-T Therapy
2:54
Moffitt Cancer Center
ASH 2024: Doris Hansen, MD on Toxicity & Response in Idecabtagene Vicleucel Therapy
1:59
Moffitt Cancer Center
ASH 2024: Dr. Sameh Gaballa, MD on High Response Rates with AZD0486 in Relapsed/Refractory DLBCL
2:47
Moffitt Cancer Center
ASH 2024: Doris Hansen, MD on Ide and Cilta-cel in Relapsed/Refractory Multiple Myeloma
1:21
Moffitt Cancer Center
ASH 2024: Onyee Chan, MD on Defining Intolerance to Tyrosine Kinase Inhibitor Treatment
1:50
Moffitt Cancer Center
Lloyd Goldstein: A Bridge Between Hearts
11:58
Moffitt Cancer Center
ASH 2024: Onyee Chan, MD Presented Phase 1 Study: CPX-351 + Gemtuzumab in AML Treatment
1:22
Moffitt Cancer Center
ASH 2024: Hayder Saeed, MD Presented Phase 1 Study of Duvelisib in Combination Oral Azacitdine
3:53
Moffitt Cancer Center
ASH 2024: Moazzam Shahzad, MD Discusses Bleeding and Thrombotic Complications of JAK Inhibitors
1:46
Moffitt Cancer Center
ASH 2024: Bijal Shah, MD Presents on the Blinatumomab + Ponatinib Effective in Ph+ ALL & CML
1:04
Moffitt Cancer Center
ASH 2024: Shrinjaya Thapa, MD Shared Outcomes in MYD88 + Waldenström Macroglobuliemia Patients
2:14
Moffitt Cancer Center
ASH 2024: Dr. Onyee Chan on Phase 1 Study of CPX-351 + Gilteritinib in FLT3-Mutated AML
1:26
Moffitt Cancer Center
ASH 2024: Mark Meads, PhD Presented Immune Evasion Linked to Daratumumab Resistance in NDMM
6:31
Moffitt Cancer Center
Chance the Elf Plays Hide-and-Seek in Moffit's Arts in Medicine Studio
0:10
Moffitt Cancer Center
Business of Biotech 2024
1:42
Moffitt Cancer Center
ASH 2024: Ken Phong Duy Dao Shared Inflammatory Transcriptional Signature in De Novo & Secondary AML
2:23
Moffitt Cancer Center
ASH 2024: Drs. David Sallman and Jeff Lancet Discuss Measurable Residual Disease in AML and MDS
4:02
Moffitt Cancer Center
ASH 2024: Jeremy DiGennaro, DO Discusses High-Risk MDS Treated Hypomethylation Agent and Venetoclax
3:19
Moffitt Cancer Center
ASH 2024: Sadegh Marzban, PhD Discusses Mechanistic Learning: Boosting Disease Prediction & Insights
4:50
Moffitt Cancer Center
ASH 2024: Fatima Tuz Zahra Presents Outcomes of Oral Azacitidine Maintenance Therapy for AML
4:18
Moffitt Cancer Center
ASH 2024: Dr. Hany Elmariah Discusses Latest Cellular Immunotherapies to Treat Hematologic Cancers
2:52
Moffitt Cancer Center
ASH 2024: Drs. Onyee Chan and Jeffrey Lancet Siscuss the Growth of Target Therapies for AML
2:37
Moffitt Cancer Center
ASH 2024: Andrew Kuykendall, MD Shares Fedratinib Could Offer New Option for MDS/MDS & CNL patients
0:48
Moffitt Cancer Center
ASH 2024: Wael Gamal PhD Discusses Endoplasmic Reticulum Stress in CLL T-cell Dysfunction
1:42
Moffitt Cancer Center
ASH 2024: Jena Schmitz Discusses How Letermovir Cuts CMV Risk in Allogeneic Transplant Patients
2:41
Moffitt Cancer Center
ASH 2024: Drs. Ariel Grajales Cruz and Jeff Lancet Discuss Bispecific Multiple Myeloma Antibodies
3:22
Moffitt Cancer Center
ASH 2024: Dr. Rachid Baz Discusses a Personalized Daratumumab-Based Response Adapted Therapy
1:47
Moffitt Cancer Center
ASH 2024: Dr. Fnu Amisha Discusses Predictive Markers After BCMA CAR T Therapy in RRMM Patients
2:16
Moffitt Cancer Center
ASH 2024: Drs. Rami Komrokji and Jeff Lancet Discuss Myelodysplastic Syndrome Treatments
5:14
Moffitt Cancer Center
ASH 2024: Drs. Julio Chavez and Jeffrey Lancet Discuss Advancements in Targeted Lymphoma Therapies
5:07
Moffitt Cancer Center
ASH 2024: Drs. Brandon Blue & Jeff Lancet Discuss Racial Disparities & Multiple Myeloma Advances
4:40
Moffitt Cancer Center
ASH 2024: Zhuoer Xie Shares New Study Compares CCUS vs Lower-Risk MDS Insights for Personalized Care
1:08